A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

Weill Medical College of Cornell University, New York

Memorial Sloan Kettering Cancer Center, New York

Montefiore Medical Center, The Bronx

Stony Brook University Medical Center, Stony Brook

Georgetown University Medical Center, Washington D.C.

Greater Baltimore Medical Center, Baltimore

University of Virginia - Emily Couric Cancer Center, Charlottesville

University of North Carolina (UNC) - Lineberger Comprehensive Cancer Center, Chapel Hill

Duke University Medical Center, Durham

East Carolina University, Greenville

Regional Medical Oncology Center, Wilson

The Winship Cancer Institute Emory University, Atlanta

University of Alabama at Birmingham, Birmingham

University of Tennessee Health Science Center, Memphis

Mercy Health - Paducah Medical Oncology and Hematology, Paducah

Fort Wayne Medical Oncology and Hematology, Fort Wayne

Washington University School of Medicine - Division of Oncology, St Louis

Tulane University Medical Center, New Orleans

MD Anderson Cancer Center, Houston

University of Utah, Salt Lake City

Cancer Care Specialists, Reno

USC Norris Comprehensive Cancer Center, Los Angeles

City of Hope National Medical Center, Duarte

Marin Cancer Care, Greenbrae

Fred Hutchinson Cancer Research Center, Seattle

Yale University School of Medicine - Yale Cancer Center, New Haven

Massachusetts General Hospital, Boston

Dana-Farber Cancer Institute, Boston

Astera HealthCare, East Brunswick

John Theurer Cancer Center At Hackensack UMC, Hackensack

University of Calgary Tom Baker Cancer Centre, Calgary

St. Paul's Hospital - Providence Health Care, Vancouver

Juravinski Cancer Centre, Hamilton

Princess Margaret Hospital, Toronto